Gennex Laboratories is currently trading at Rs. 3.10, up by 0.16 points or 5.44% from its previous closing of Rs. 2.94 on the BSE.
The scrip opened at Rs. 3.15 and has touched a high and low of Rs. 3.23 and Rs. 3.06 respectively. So far 309358 shares were traded on the counter.
The BSE group ‘X’ stock of face value Rs. 1 has touched a 52 week high of Rs. 4.07 on 06-Jun-2019 and a 52 week low of Rs. 1.32 on 24-Mar-2020.
Last one week high and low of the scrip stood at Rs. 3.23 and Rs. 2.70 respectively. The current market cap of the company is Rs. 40.48 crore.
The promoters holding in the company stood at 22.05%, while Non-Institutions held 77.95% respectively.
Gennex Laboratories has received World Health Organisation Good Manufacturing Practices (WHO-GMP) Certificate from the Drug Control Administration, Government of Telangana for a period of 3 years from the date of issue. The list of products approved under WHO-GMP Certificate Scheme for export purpose includes Guaifenesin USP/BP/IP/EP, Methocarbamol USP/IP, Phenazopyridine HCI USP, Mephenesin BP, Chlorophenesin BP and Allopurinol USP.
Gennex Laboratories (formerly Prudential Pharmaceuticals) is a public limited company established in the year 1995 and has been engaged in the manufacturing of bulk drugs and intermediates.
